The real incidence of cardiac amyloidosis (CA) is still unknown, and this is, at least in part, due to difficulties in confirming diagnosis. Currently, however, different imaging exams and genetic tests can, in association with clinical presentation, confirm diagnosis. Cardiac magnetic resonance (CMR) can contribute to confirmation of diagnosis and, more recently, to the screening of family members of carriers of hereditary forms of CA.1 , 2 In this article, we will review the contributions of CMR in relation to […]